Sex disparities in lung cancer: Results of the KBP-2020-CPHG study
D. Templement-Grangerat, Chrystèle Locher, Anne Catherine Neidhardt, Mathieu Fore et autres
1 citationLung Cancer
Hugues Morel
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
161Publications signalées
1460Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsCancer Genomics and DiagnosticsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesRNA modifications and cancer
Publications récentes
Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study
Sebastien Couraud, Emmanuel Grolleau, J. Letreut, Claudia Rizzo et autres
0 citationsLung Cancer
Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution
Romain Corre, Isabelle Monnet, L. Moreau, J. Pinsolle et autres
0 citationsEuropean Journal of Cancer
Five-year overall survival in lung adenocarcinoma: Real-world results from three French nationwide cohorts (2000–2010–2020).
D. Debieuvre, Federico Di Meglio, Le Garff Gwenaëlle, Thomas Laurent et autres
0 citationsJournal of Clinical Oncology
Supplementary Figure S2 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Figure S1 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Figure S4 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Material SM2 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Study Protocol from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Figure Legends SL1 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Table TS1 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
Supplementary Material SM1 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
Fabrice Barlési, Pascale Tomasini, Maryam Karimi, Stefan Michiels et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.